Package 76420-318-60

{"route": ["ORAL"], "spl_id": "327e6538-4b98-1f09-e063-6294a90a2f75", "openfda": {"unii": ["WY6W63843K"], "rxcui": ["854880", "854894"], "spl_set_id": ["30c057fb-2e1b-4b9c-8c8a-79c322151e61"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-318-01)", "package_ndc": "76420-318-01", "marketing_start_date": "20250411"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-318-30)", "package_ndc": "76420-318-30", "marketing_start_date": "20250411"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-318-60)", "package_ndc": "76420-318-60", "marketing_start_date": "20250411"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-318-90)", "package_ndc": "76420-318-90", "marketing_start_date": "20250411"}], "brand_name": "ZOLPIDEM TARTRATE", "product_id": "76420-318_327e6538-4b98-1f09-e063-6294a90a2f75", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Depression [PE]", "GABA A Receptor Positive Modulators [MoA]", "gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]"], "product_ndc": "76420-318", "dea_schedule": "CIV", "generic_name": "Zolpidem Tartrate", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZOLPIDEM TARTRATE", "active_ingredients": [{"name": "ZOLPIDEM TARTRATE", "strength": "6.25 mg/1"}], "application_number": "ANDA078970", "marketing_category": "ANDA", "marketing_start_date": "20140411", "listing_expiration_date": "20261231"}